Elron Ventures

Elron Ventures is a venture capital firm based in Tel Aviv, Israel, specializing in seed and early-stage investments. Established in 1962, it focuses on identifying and nurturing innovative technologies within sectors such as enterprise software, cybersecurity, and medical technology. The firm primarily invests in companies located in Israel and aims to support entrepreneurs in building transformative businesses. Throughout its history, Elron has been associated with the development of numerous prominent Israeli high-tech companies, reinforcing its position as a leader in the venture capital landscape. By concentrating on sectors that drive technological advancement, Elron Ventures continues to play a significant role in fostering innovation within the Israeli ecosystem.

Yaron Elad

CEO and Managing Partner

Elik Etzion

Managing Partner

Zohar Rozenberg

Venture Partner

Zvika Slovin

Venture Partner

52 past transactions

Wonder Robotics

Seed Round in 2022
Wonder Robotics specializes in developing advanced autonomous systems for drones, including electric vertical take-off and landing (eVTOL) vehicles and urban air mobility (UAM) applications. The company employs sophisticated computer vision technology that mimics human visual perception, combining short-range 3D depth sensing with long-range 2D vision. This innovative approach significantly enhances a drone's ability to perceive its environment, allowing for more accurate classification and motion detection. One of its flagship products, WonderLand, enables drones to autonomously land on uncharted and unprepared sites without the need for operator supervision. It conducts complex geometric analyses using 3D sensors and proprietary algorithms to assess landing areas for obstacles and hazards, ensuring safe and precise landings. This technology not only enhances operational safety but also expands the potential applications of drones in various sectors, including commercial delivery, infrastructure inspection, and mapping.

Sixgill Ltd

Series B in 2022
Sixgill Ltd is a leading provider of web cyber security services, established in 2014 and based in Tel Aviv-Yafo, Israel. The company specializes in cyber intelligence, which is essential for organizations to prevent, detect, and mitigate cyber threats. Its software as a service (SaaS) platform offers secure cloud infrastructure and includes an on-premise web threat intelligence solution, along with analyst support. By leveraging artificial intelligence and machine learning, Sixgill automates the entire cyber intelligence production cycle, from monitoring to extraction to actionable insights. The company maps the Dark Web as a social network to identify relevant threat actors and provides real-time alerts when threats are detected. Its advanced data mining and behavioral analytics deliver a comprehensive view of threats, enabling rapid response to cyber incidents. Sixgill serves a diverse clientele, including Fortune 500 companies and federal agencies, effectively enhancing their cybersecurity posture.

Canonic Security

Seed Round in 2022
Canonic Security is a software-as-a-service (SaaS) application security platform that focuses on enhancing the security of third-party applications and integrations. The platform continuously profiles applications and user accounts, identifying suspicious or non-compliant behavior to minimize the SaaS attack surface. By providing access intelligence and insights into vulnerabilities, Canonic Security enables security teams to quickly detect SaaS-native threats and respond effectively. Its comprehensive monitoring capabilities streamline the review process for applications, allowing organizations to safely leverage the benefits of a diverse app ecosystem while mitigating risks associated with third-party access.

Sayata

Series A in 2021
Sayata Labs Ltd., founded in 2016 and based in Tel Aviv, Israel, specializes in data-driven cyber security solutions tailored for the insurance industry. The company offers advanced cyber analytics that enhance the assessment of cyber risk, providing valuable insights for better risk differentiation and aggregation management. Sayata Labs' proprietary information enables businesses to effectively mitigate their cyber risks while assisting insurance partners in profitably expanding their cyber insurance portfolios. Through its innovative solutions, Sayata Labs contributes to a more secure and informed cyber insurance landscape.

Scribe Security

Seed Round in 2021
Developer of a SaaS platform designed for securing software across supply chains. The company's platform allows the development, distribution, and maintenance of code produced within the organization, while also verifying code components' integrity, building and enforcing software development life cycle processes, provenance, authenticity, and reputation, enabling the organization with visibility and assurance of the entire software development life cycle from early design stages to final deployment.

Notal Vision

Series D in 2021
Notal Vision develops home-based monitoring systems for patients with age-related macular degeneration. Founded in 2000, the company operates from offices in Tel Aviv, Israel, and Manassas, Virginia. It offers the ForeseeHome device, which enables patients to detect changes in their vision associated with the condition. This device employs Preferential Hyperacuity Perimetry technology to identify subtle vision alterations. Additionally, Notal Vision provides the Notal OCT Analyzer, an algorithm that automates the detection of pathological fluid in exudative retinal diseases, and utilizes optical coherence tomography for noninvasive imaging. The company's platform incorporates AI algorithms to enhance diagnostic decision-making and facilitate patient-activated treatment options. By extending eye disease management from clinical settings to home environments, Notal Vision aims to improve visual outcomes and enable early intervention by eye care professionals.

ZenGo

Series A in 2021
Developer of a non-custodial digital currency wallet designed to make the global crypto economy more accessible. The company's digital wallets let people buy and sell cryptocurrencies and generate and manage private keys that reduce and fix the problems of security breaches and human error, enabling cryptocurrency traders and investors to manage their digital assets and investment portfolios in a convenient, secure, and hassle-free manner.

BrainsGate

Series F in 2020
BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

Sixgill Ltd

Series B in 2020
Sixgill Ltd is a leading provider of web cyber security services, established in 2014 and based in Tel Aviv-Yafo, Israel. The company specializes in cyber intelligence, which is essential for organizations to prevent, detect, and mitigate cyber threats. Its software as a service (SaaS) platform offers secure cloud infrastructure and includes an on-premise web threat intelligence solution, along with analyst support. By leveraging artificial intelligence and machine learning, Sixgill automates the entire cyber intelligence production cycle, from monitoring to extraction to actionable insights. The company maps the Dark Web as a social network to identify relevant threat actors and provides real-time alerts when threats are detected. Its advanced data mining and behavioral analytics deliver a comprehensive view of threats, enabling rapid response to cyber incidents. Sixgill serves a diverse clientele, including Fortune 500 companies and federal agencies, effectively enhancing their cybersecurity posture.

Zengold

Angel Round in 2019
Shenzhen ZenGold Culture Development Co., LTD. operates in the field of blockchain technology, specifically focusing on the trading and management of gold assets. The company has developed a decentralized application that utilizes blockchain to facilitate gold spot trading, providing users with real-time price quotes sourced from the Shanghai Gold Exchange. ZenGold also offers custody services for physical gold assets and enables delivery options. The physical assets are underwritten by Sunshine Insurance Company, ensuring security and reliability for users in China and beyond.

Sayata

Seed Round in 2019
Sayata Labs Ltd., founded in 2016 and based in Tel Aviv, Israel, specializes in data-driven cyber security solutions tailored for the insurance industry. The company offers advanced cyber analytics that enhance the assessment of cyber risk, providing valuable insights for better risk differentiation and aggregation management. Sayata Labs' proprietary information enables businesses to effectively mitigate their cyber risks while assisting insurance partners in profitably expanding their cyber insurance portfolios. Through its innovative solutions, Sayata Labs contributes to a more secure and informed cyber insurance landscape.

Alcide

Series A in 2018
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.

ZenGo

Seed Round in 2018
Developer of a non-custodial digital currency wallet designed to make the global crypto economy more accessible. The company's digital wallets let people buy and sell cryptocurrencies and generate and manage private keys that reduce and fix the problems of security breaches and human error, enabling cryptocurrency traders and investors to manage their digital assets and investment portfolios in a convenient, secure, and hassle-free manner.

ZenGo

Seed Round in 2018
Developer of a non-custodial digital currency wallet designed to make the global crypto economy more accessible. The company's digital wallets let people buy and sell cryptocurrencies and generate and manage private keys that reduce and fix the problems of security breaches and human error, enabling cryptocurrency traders and investors to manage their digital assets and investment portfolios in a convenient, secure, and hassle-free manner.

Alcide

Seed Round in 2017
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.

Nitinotes

Seed Round in 2016
Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

Alcide

Seed Round in 2016
Alcide.IO Ltd. specializes in security and management tools designed for hybrid, multi-cloud, and multi-compute data centers, with a strong focus on Kubernetes environments. Founded in 2016 and based in Tel Aviv-Yafo, Israel, the company offers an end-to-end Kubernetes security platform that includes solutions such as Alcide Kubernetes Advisor, Alcide kAudit, and Alcide Runtime. These tools help organizations secure their Kubernetes deployments by addressing configuration risks, network security events, and providing a unified policy framework. Alcide's offerings are compatible with major cloud platforms like AWS, Azure, and Google Cloud, enabling businesses to scale their Kubernetes environments while maintaining robust security measures. Its platform aims to protect against various cyber threats, including internal malicious activities and data exfiltration, ensuring the secure operation of business applications in cloud deployments.

Sixgill Ltd

Series A in 2016
Sixgill Ltd is a leading provider of web cyber security services, established in 2014 and based in Tel Aviv-Yafo, Israel. The company specializes in cyber intelligence, which is essential for organizations to prevent, detect, and mitigate cyber threats. Its software as a service (SaaS) platform offers secure cloud infrastructure and includes an on-premise web threat intelligence solution, along with analyst support. By leveraging artificial intelligence and machine learning, Sixgill automates the entire cyber intelligence production cycle, from monitoring to extraction to actionable insights. The company maps the Dark Web as a social network to identify relevant threat actors and provides real-time alerts when threats are detected. Its advanced data mining and behavioral analytics deliver a comprehensive view of threats, enabling rapid response to cyber incidents. Sixgill serves a diverse clientele, including Fortune 500 companies and federal agencies, effectively enhancing their cybersecurity posture.

Coramaze Technologies

Series A in 2015
Coramaze Technologies GmbH is a medical device company focused on developing minimally invasive solutions for heart diseases. The company is known for its Mitramaze valve repair system, a catheter-based device designed to be implanted directly into the beating heart. This innovative system specifically targets inoperable and asymptomatic patients suffering from functional mitral regurgitation, a condition often resulting from heart enlargement due to heart attacks or heart failure. Founded in 2013, Coramaze Technologies is headquartered in Essen, Germany, and aims to offer a less invasive treatment option for patients who would otherwise have limited therapeutic alternatives.

POCARED Diagnostics

Venture Round in 2015
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.

CartiHeal

Series D in 2015
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

BrainsGate

Venture Round in 2015
BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

POCARED Diagnostics

Series G in 2014
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.

CartiHeal

Venture Round in 2013
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

POCARED Diagnostics

Series F in 2013
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.

CartiHeal

Venture Round in 2012
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

CartiHeal

Series D in 2012
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

BrainsGate

Series C in 2011
BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

CartiHeal

Series C in 2011
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

POCARED Diagnostics

Series F in 2011
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.

BPT

Series B in 2009
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.

CartiHeal

Series A in 2009
Cartiheal Ltd., a medical device company, develops implants for the regeneration of cartilage and bone disorders. The company offers Agili-C, an off the shelf and cell-free implant that regenerates hyaline cartilage and its underlying subchondral bone. Its implant is used for the treatment of focal articular cartilage and osteochondral defects. The company was founded in 2009 and is based in Kfar Sava, Israel.

PLYmedia

Series A in 2009
PLYmedia, Inc. is an ad-tech company established in 2006 and headquartered in Palo Alto, California. The company focuses on creating performance-based advertising solutions, primarily through its flagship product, PLYexchange, which integrates a highly accurate prediction engine and real-time bidding (RTB) capabilities. PLYmedia also offers PLYvideo, a specialized video advertising solution for ad networks and agencies, and Adk2, a customizable performance-based ad exchange. These products are designed to enhance the performance of internet advertising while safeguarding advertisers and publishers from low-quality supply and demand. By collaborating with ad networks, PLYmedia aims to build a global ecosystem centered on performance-driven advertising.

BrainsGate

Series C in 2008
BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

ChipX

Series B in 2008
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.

Aqwise

Venture Round in 2008
Aqwise - Wise Water Technologies Ltd. is a world leader in the development and implementation of innovative wastewater treatment solutions for the industrial and municipal markets. Aqwise's family of solutions increases BOD and nutrient removal capacity in wastewater treatment plants, offering enhanced utilization of existing reactors and unique efficiencies in the implementation of new ones. From process design through project supervision and all the way to full turn-key and financing solutions, Aqwise provides wastewater treatment professionals with a variety of solutions for every need.

Safend

Series C in 2008
Safend specializes in Data Leakage Prevention (DLP) solutions aimed at safeguarding enterprise endpoints from data loss, misuse, and theft. Its flagship product, the Safend Data Protection Suite, operates on a streamlined architecture that includes a single server, management console, and agent. The suite comprises several modular components: Safend Encryptor for encrypting internal hard drives, Safend Protector for controlling ports and external media, Safend Inspector for monitoring and blocking sensitive content transfers, Safend Discoverer for mapping and classifying sensitive data, Safend Reporter for compliance reporting, and Safend Auditor for auditing connected devices and networks. The company serves a diverse clientele, including governmental agencies, healthcare organizations, and businesses in finance and retail, helping them adhere to regulations such as HIPAA, PCI, and SOX. Safend distributes its products globally through a network of resellers and partners, focusing on security-conscious organizations.

Medingo Medical Solutions

Venture Round in 2007
Medingo develops and produces miniature medical devices for people with diabetes. The company's flagship product is the Solo MicroPump, a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or needles. The company was founded in 2005 and is based in Yoqneam Illit, Israel and the US Corporate Office is in Tampa, FL.

Enure Networks

Venture Round in 2007
Enure Networks, Ltd. specializes in home-network management and self-healing software solutions designed to enhance the installation and maintenance of home and small office/home office (SOHO) networked services. The company provides a range of solutions, including high-speed internet for home users, VoIP services that manage performance and connectivity, security solutions that proactively address potential risks, and IPTV solutions that simplify the complexities of IPTV delivery. Enure Networks also offers a True Information & Control server that facilitates the management of data and actions related to home networks. Founded in 2003 and based in Herzeliya, Israel, the company has operations in the United States and Europe, aiming to deliver seamless broadband services for service providers.

MuseStorm

Series A in 2007
MuseStorm provides a platform for authoring, distributing, analyzing, and monetizing widgets. The platform is made available to large marketing clients that pay on a CPM or pre-paid campaign basis. It has the ability to produce variations of widgets for different environments, such as [MySpace](http://www.crunchbase/organization/myspace), [Facebook](http://www.crunchbase/organization/facebook), iGoogle, [Netvibes](http://www.crunchbase.com/organization/netvibes), and [PageFlakes](http://www.crunchbase.com/organization/pageflakes). There is also limited support for desktop environments. MuseStorm's analytics gives marketers insight into how many times their widgets have been viewed, how users have interacted with them, and where. Competitors include [Widgetbox](http://crunchbase.com/organization/widgetbox), [Clearspring](http://crunchbase.com/organization/clearspring), and [Sprout](http://www.crunchbase.com/organization/sprout), although these companies provide their platforms for free and operate as ad networks of sorts. MuseStorm clients include Simon & Schuster (BookVideos), CBS (The ShowBuzz), and [Microsoft](http://www.crunchbase.com/organization/microsoft), which launched a Halo 3 [Facebook](http://www.crunchbase.com/organization/facebook) application with the service. MuseStorm distributes its widgets with [Gigya](http://www.crunchbase.com/organization/musestorm). Its business development is conducted in San Francisco, but engineering efforts take place in Israel.

POCARED Diagnostics

Venture Round in 2007
POCARED Diagnostics Ltd. is a medical device company based in Rehovot, Israel, specializing in in-vitro diagnostics. Founded in 2004, the company has developed a next-generation microbiology platform known as the P-1000, which offers a fully automated and reagent-free solution for real-time analysis of human fluids and specimens. This innovative platform enables rapid detection, identification, and antibiotic sensitivity assessment of pathogenic bacteria and yeast, significantly reducing the time required for result reporting from several days to just a few minutes. By providing multi-source detection and quantification, POCARED Diagnostics aims to enhance the accuracy and efficiency of infectious disease diagnosis, making it easier for healthcare providers to make informed decisions. As of September 2020, POCARED operates as a subsidiary of Naftali Investments Ltd.

RADLIVE

Series A in 2007
Founded in 2005, RADLIVE develops high definition telephony technologies, products and applications. RADLIVE's innovative solutions and unique technology will transform the way users and organizations all over the world communicate and collaborate with each other. RADLIVE is a member of the RAD Group, a collection of independent companies that develop, manufacture and market solutions for diverse segments of the networking and telecommunications industry. Closed February 2010.

Journeys

Seed Round in 2007
Journeys, based in Israel, is a both a virtual world and MMOG (Massively Multiplayer Online Game). Journeys is a participant at the 2008 IsraelWebTour.

BPT

Series A in 2007
BPT is developing and commercializing advanced membranes-based separation solutions addressing the unique needs of the water and wastewater treatment for key industrial processes. BPT patented chemically-stable membrane technology enable customers in the landfill, mining, chemical, biopharma and food industries to comply with the environmental regulations, reuse water and reduce production costs. BPT membranes are field proven to enable lowest cost reclamation of some of the most aggressive and vexing industrial waste water streams.

Enure Networks

Series A in 2006
Enure Networks, Ltd. specializes in home-network management and self-healing software solutions designed to enhance the installation and maintenance of home and small office/home office (SOHO) networked services. The company provides a range of solutions, including high-speed internet for home users, VoIP services that manage performance and connectivity, security solutions that proactively address potential risks, and IPTV solutions that simplify the complexities of IPTV delivery. Enure Networks also offers a True Information & Control server that facilitates the management of data and actions related to home networks. Founded in 2003 and based in Herzeliya, Israel, the company has operations in the United States and Europe, aiming to deliver seamless broadband services for service providers.

Safend

Series B in 2006
Safend specializes in Data Leakage Prevention (DLP) solutions aimed at safeguarding enterprise endpoints from data loss, misuse, and theft. Its flagship product, the Safend Data Protection Suite, operates on a streamlined architecture that includes a single server, management console, and agent. The suite comprises several modular components: Safend Encryptor for encrypting internal hard drives, Safend Protector for controlling ports and external media, Safend Inspector for monitoring and blocking sensitive content transfers, Safend Discoverer for mapping and classifying sensitive data, Safend Reporter for compliance reporting, and Safend Auditor for auditing connected devices and networks. The company serves a diverse clientele, including governmental agencies, healthcare organizations, and businesses in finance and retail, helping them adhere to regulations such as HIPAA, PCI, and SOX. Safend distributes its products globally through a network of resellers and partners, focusing on security-conscious organizations.

BrainsGate

Venture Round in 2005
BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

Teledata Networks

Venture Round in 2005
Teledata Networks is a leading global provider of innovative Access Network solutions and products for telecom service providers. The company creates solutions that enable a smooth migration path to Next Generation Networks (NGN) and support a full Triple Play service portfolio.

ChipX

Venture Round in 2004
ChipX, Inc. is a Mixed-Signal ASIC company with the broadest offering of value-added ASIC solutions, including Standard Cell, Structured ASIC and Hybrid ASIC technology. ChipX has unique expertise in PCI Express, USB 2.0, DDR/DDR2 and data conversion mixed-signal cores; all are silicon proven and certified and they can be integrated in customers’ ASICs with a record first-time to market success. ChipX products are widely used in industrial applications, medical equipment and military/aerospace systems. Headquartered in Santa Clara, CA, ChipX is a privately held corporation, with a Research and Development subsidiary in Israel.

ForeseeHome

Series A in 2003
Notal Vision is developing the first comprehensive diagnostic solution for the early detection and frequent monitoring of Age-Related Macular Degeneration (AMD), the leading cause of blindness in the western world today. Early detection of ARM can allow doctors to treat patients at an earlier stage and possibly prevent any loss of sight. A true pioneer in the eye care industry, Notal Vision has developed and introduced the first home-based monitoring system for AMD patients, the ForeseeHome™ AMD Monitoring Program.

Chip Express

Venture Round in 2002
Fit the CHIP Express™ digital diesel tuning box for more torque too. You'll immediately notice better acceleration from low down in the rev range and when using taller gears. And that means more pulling power - precisely what you need if you tow a caravan, a horse box, a boat or if you drive a heavily laden vehicle like a van or pickup.

Mediagate

Venture Round in 2000
mediagate develops and sells iPost Universal Messaging, a carrier-class universal messaging solution. iPost Universal Messaging is comprised of iPost application software and carrier-grade, third-party hardware. iPost Universal Messaging enables subscribers to manage multi-media messages, voice, fax, email and page, from within a single mailbox using any email client (Outlook, Hotmail, Netscape Mail, Eudora, etc.), from anywhere in the world, any time of the day or week. Subscribers can use any telephone, mobile phone, PDA, computer, laptop, fax machine, and WAP and SMS-enabled device to manage their messages.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.